BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6639104)

  • 1. [Experimental animal information file: effect of bestatin in muscular dystrophy in mice].
    Kawamata J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2425-6. PubMed ID: 6639104
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of murine muscular dystrophy with the protease inhibitor bestatin.
    Tsuji S; Matsushita H
    J Neurol Sci; 1986 Feb; 72(2-3):183-94. PubMed ID: 3711932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationships between enzyme inhibitors and function of mammalian cells.
    Aoyagi T; Umezawa H
    Acta Biol Med Ger; 1981; 40(10-11):1523-9. PubMed ID: 7044007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic trials on progressive muscular dystrophy.
    Satoyoshi E
    Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a cysteine protease inhibitor EST on urinary 3-methylhistidine in dystrophic hamsters (BIO 14.6)].
    Terao T; Mashino K; Takatsu M; Hiraguchi M
    Rinsho Shinkeigaku; 1986 Nov; 26(11):1218-23. PubMed ID: 3549099
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice.
    Komatsu K; Inazuki K; Hosoya J; Satoh S
    Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy.
    Lescop C; Herzner H; Siendt H; Bolliger R; Henneböhle M; Weyermann P; Briguet A; Courdier-Fruh I; Erb M; Foster M; Meier T; Magyar JP; von Sprecher A
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5176-81. PubMed ID: 16185867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of muscle diseases, Part III: Compilation of therapeutic trials for hereditary muscular dystrophy.
    Cosmos E; Butler J
    Muscle Nerve; 1980; 3(5):427-35. PubMed ID: 7421876
    [No Abstract]   [Full Text] [Related]  

  • 9. The stabilizing effect of bestatin on the resting membrane potentials of X-linked muscular dystrophy mice.
    Kishi M; Kurihara T; Hidaka T; Kinoshita M
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):595-600. PubMed ID: 2074619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of life span of dystrophic hamster by cysteine proteinase inhibitor, loxistation (EST).
    Tamai M; Omura S; Kimura M; Hanada K; Sugita H
    J Pharmacobiodyn; 1987 Nov; 10(11):678-81. PubMed ID: 3482108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
    Bizario JC; Cerri DG; Rodrigues LC; Oliveira GL; Nomizo A; de Araujo DD; Fukuhara PS; Ribeiro JC; de Castro FA; Costa MC
    J Neuroimmunol; 2009 Jul; 212(1-2):93-101. PubMed ID: 19508953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of 5-hydroxytryptamine antagonists on inherited muscular dystrophy in the chicken and hamster [proceedings].
    Barnard EA; Barnard PJ
    J Physiol; 1978 May; 278():29P-30P. PubMed ID: 671302
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the pathogenesis of muscular dystrophy: superoxide dismutase activity in avian muscular dystrophy].
    Mizuno Y; Joshita Y; Kaneko J
    No To Shinkei; 1982 Jul; 34(7):667-72. PubMed ID: 7138694
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteinase inhibitors and muscle degeneration.
    Stracher A
    Muscle Nerve; 1982; 5(6):494. PubMed ID: 7133046
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of thiorphan, bestatin and captopril on the Lewis lung carcinoma metastases in mice.
    Kowalski J; Belowski D; Madej A; Herman ZS
    Pol J Pharmacol; 1995; 47(5):423-7. PubMed ID: 8868134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of drug regimen exceeds electrostimulation in treatment of avian muscular dystrophy.
    Hudecki MS; Povoski SP; Gregorio CC; Granchelli JA; Pollina CM
    J Appl Physiol (1985); 1995 Jun; 78(6):2014-9. PubMed ID: 7665393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A drug inhibits the mitochondrial protease inducing calmitine deficiency in skeletal muscle of patients with Duchenne's muscular dystrophy and dy/dy dystrophic mice.
    Lucas-Heron B
    Biochem Biophys Res Commun; 1997 Mar; 232(2):559-61. PubMed ID: 9125222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of bestatin and thiorphan in mice.
    Kowalski J; Belowski D; Madej A; Herman ZS
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):265-71. PubMed ID: 8744646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug evaluation in muscular dystrophy of the chicken.
    Entrikin RK; Patterson GT; Wilson BW
    Muscle Nerve; 1982 Apr; 5(4):321-7. PubMed ID: 7099198
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
    Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
    Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.